🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the safety, tolerability, and immun...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2021-07-08
Trial ID
NCT04927585
Treatments Being Tested
This study evaluates the efficacy, safety and immunogenicity of different f...
Status
Completed
Location
George Washington University
Start Date
2018-03-01
Trial ID
NCT03172975
This protocol is for a phase 1, randomized, single-blinded study to evaluat...
Status
Completed
Location
Rockefeller University
Start Date
2012-09
Trial ID
NCT01864876
Treatments Being Tested
This pilot phase I clinical trial studies the side effects and best dose of...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2014-11-17
Trial ID
NCT02180698
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Alabama CRS
Start Date
2017-08-22
Trial ID
NCT03220724
This is a single arm, open-label, single center study evaluating the safety...
Status
Completed
Location
University of Washington Medical Center, Seattle Cancer Care Alliance
Start Date
2014-01
Trial ID
NCT02035657
Treatments Being Tested
The goal of this study is to evaluate the safety, tolerability and immunoge...
Status
Completed
Location
Research Site
Start Date
2015-01-05
Trial ID
NCT02289820
This study evaluated the safety and immune response in healthy HIV-exposed ...
Status
Completed
Location
Perinatal HIV Research Unit (PHRU), Soweto CRS
Start Date
2020-11-10
Trial ID
NCT04607408
Treatments Being Tested
The purpose of the study is to evaluate the safety, tolerability, and immun...
Status
Not Yet Recruiting
Location
Brigham and Women's Hospital
Start Date
2026-09-01
Trial ID
NCT07675629
This is a Phase I, multi-center, multiple ascending dose study to evaluate ...
Status
Completed
Location
Scottsdale Healthcare
Start Date
2013-11
Trial ID
NCT02015416
Treatments Being Tested